Clinical Heterogeneity in MT-ATP6 Pathogenic Variants: Same Genotype—Different Onset (original) (raw)

Abstract

Human mitochondrial disease exhibits large variation of clinical phenotypes, even in patients with the same causative gene defect. We illustrate this heterogeneity by confronting clinical and biochemical data of two patients with the uncommon pathogenic homoplasmic NC_012920.1(MT-ATP6):m.9035T>C variant in MT-ATP6. Patient 1 presented as a toddler with severe motor and speech delay and spastic ataxia without extra-neurologic involvement. Patient 2 presented in adolescence with ataxia and ophthalmoplegia without cognitive or motor impairment. Respiratory chain complex activities were normal in cultured skin fibroblasts from both patients when calculated as ratios over citrate synthase activity. Native gels found presence of subcomplexes of complex V in fibroblast and/or skeletal muscle. Bioenergetic measurements in fibroblasts from both patients detected reduced spare respiratory capacities and altered extracellular acidification rates, revealing a switch from mitochondrial respir...

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (44)

  1. Jonckheere, A.I.; Smeitink, J.A.; Rodenburg, R.J. Mitochondrial ATP synthase: architecture, function and pathology. J. Inherit. Metab. Dis. 2012, 35, 211-225.
  2. Anderson, S.; Bankier, A.T.; Barrell, B.G.; et al. Sequence and organization of the human mitochondrial genome. Nature 1981, 290, 457-465.
  3. Wittig, I.; Meyer, B.; Heide, H.; Steger, M.; Bleier, L; Wumaier, Z.; Karas, M.; Schägger, H. Assembly and oligomerization of human ATP synthase lacking mitochondrial subunits a and A6L. Biochim. Biophys. Acta 2010, 1797, 1004-1011.
  4. Wittig, I.; Schägger, H. Structural organization of mitochondrial ATP synthase. Biochim. Biophys. Acta 2008, 1777, 592-598.
  5. Ganetzky, R.D.; Stendel, C.; McCormick, E.M.; Zolkipli-Cunningham, Z.; Goldstein, A.C.; Klopstock, T.; Falk, M.J. MT-ATP6 mitochondrial disease variants: Phenotypic and biochemical features analysis in 218 published cases and cohort of 14 new cases. Hum. Mutat. 2019, 40, 499-515.
  6. Holt, I.J.; Harding, A.E.; Petty, R.K.; Morgan-Hughes, J.A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. 1990, 46, 428-433.
  7. Van der Westhuizen, F.H.; Smet, J.; Levanets, O.; Meissner-Roloff;
  8. M. Louw, R; Van Coster, R; Smuts, I. Aberrant synthesis of ATP synthase resulting from a novel deletion in mitochondrial DNA in an African patient with progressive external ophthal- moplegia. J. Inherit. Metab. Dis. 2010, 33 (Suppl. 3), S55-62.
  9. Stendel, C.; Neuhofer, C.; Floride, E.; Yuqing, S.; Ganetzky, R.D.; Park, J.; Freisinger, P.; Kornblum, C.; Kleinle, S.; Schöls, L. et al. Delineating MT-ATP6-associated disease: From isolated neuropathy to early onset neurodegeneration. Neurol. Genet. 2020, 6, e393.
  10. Dautant, A.; Meier, T.; Hahn, A.; Tribouillard-Tanvier, D.; di Rago, J.P.; Kucharczyk, R. ATP Synthase Diseases of Mitochondrial Genetic Origin. Front. Physiol. 2018, 9, 329.
  11. Nolte, D.; Kang, J.S.; Hofmann, A.; Schwaab, E.; Krämer, H.H.; Müller, U. Mutations in MT-ATP6 are a frequent cause of adult- onset spinocerebellar ataxia. J. Neurol. 2021, 268, 4866-4873.
  12. Wong, L.J. Diagnostic challenges of mitochondrial DNA disorders. Mitochondrion 2007, 7, 45-52.
  13. Sikorska, M.; Sandhu, J.K.; Simon, D.K.; Pathiraja, V.; Sodja, C.; Li, Y.; Ribecco-Lutkiewicz, M.; Lanthier, P.: Borowy-Borowski, H.; Upton, A. et al. Identification of ataxia-associated mtDNA mutations (m.4052T>C and m.9035T>C) and evaluation of their pathogenicity in transmitochondrial cybrids. Muscle Nerve. 2009, 40, 381-394.
  14. Pfeffer G, Blakely EL, Alston CL, et al. Adult-onset spinocerebellar ataxia syndromes due to MTATP6 mutations. J. Neurol. Neurosurg. Psychiatry 2012, 83, 883-886.
  15. Ng, Y.S.; Martikainen, M.H.; Gorman, G.S.; Blain, A.; Bugiardini, E.; Bunting, A.; Schaefer, A.M.; Alston, C.L.; Blakely, E.L.; Sharma, S. et al. Pathogenic variants in MT-ATP6: A United Kingdom-based mitochondrial disease cohort study. Ann. Neurol. 2019, 86, 310-315.
  16. Rucheton, B.; Jardel, C.; Filaut, S.; Del Mar Amador, M.; Maisonobe, T.; Serre, I.; Romero, N.B.; Leonard-Louis, S.; Haraux, F; Lombès, A. Homoplasmic deleterious MT-ATP6/8 mutations in adult patients. Mitochondrion. 2020, 55, 64-77.
  17. Garret, P.; Bris, C.; Procaccio, V.; Amati-Bonneau, P.; Vabres, P.; Houcinat, N.; Tisserant, E.; Feillet, F.; Bruel, A-L.; Quéré, V. et al. Deciphering exome sequencing data: Bringing mitochondrial DNA variants to light. Hum. Mutat. 2019, 40, 2430-2443.
  18. Haraux, F.; Lombès, A. Kinetic analysis of ATP hydrolysis by complex V in four murine tissues: Towards an assay suitable for clinical diagnosis. PLoS ONE 2019, 14, e0221886.
  19. De, A.; Campbell, C. A novel interaction between DNA ligase III and DNA polymerase ɣ plays an essential role in mitochondrial DNA stability. Biochem. J. 2007, 402, 175-186.
  20. Hatefi, Y.; Stiggall, D.L. Preparation and properties of succinate: ubiquinone oxidoreductase (complex II). Methods Enzymol. 1978, 53, 21-27.
  21. DiMauro, S.; Servidei, S.; Zeviani, M.; DiRocco, M.; DeVivo, D.C.; Uziel, G.: Berry, K.; Hoganson, G.; Johnsen, S.D. Cytochrome c oxidase deficiency in Leigh syndrome. Ann. Neurol. 1987, 22, 498-506.
  22. Birch-Machin, M.A.; Shepherd, I.M.; Watmough, N.J.; Sherratt, H.S.; Bartlett, K.; Darley-Usmar, V.M.; Milligan, D.W.; Welch, R.J.; Aynsley-Green, A.; Turnbull, D.M. Fatal lactic acidosis in infancy with a defect of complex III of the respiratory chain. Pediatr. Res. 1989, 25, 553-559.
  23. Rustin, P.; Chretien, D.; Bourgeron, T.; Gérard, B.; Rötig, A.; Saudubray, J.M.; Munnich, A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta. 1994, 228, 35-51.
  24. Janssen, A.J.; Trijbels, F.J.; Sengers, R.C.; Smeitink, J. A.; Van den Heuvel, L.P.; Wintjes, L.T.; Stoltenborg-Hogenkamp, B.J.; Rodenburg, R.J. Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clin. Chem. 2007, 53, 729-734.
  25. Sottocasa, G.L.; Kuylenstierna, B.; Ernster, L.; Bergstrand, A. An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J. Cell Biol. 1967, 32, 415-438.
  26. Srere, P.A. Citrate synthase. In Methods in Enzymology; Colwick, S.F., Kaplan, N.O.; Academic PressCambridge, MA, USA, 1969; 3-11; Volume 13.
  27. Fischer, J.C.; Ruitenbeek, W.; Gabreëls, F.J.; Janssen, A.J.; Renier, W.O.; Sengers, R.C.; Stadhouders, A.M.; ter Laak, H.J.; Trijbels, J.M.; Veerkamp, J.H.; A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q. Eur J Pediatr 1986;144:441-4.
  28. Mayr, J.A.; Paul, J.; Pecina, P.; Kurnik, P.; Förster, H.; Fötschl, U.; Sperl, W.; Houstek, J. Reduced respiratory control with ADP and changed pattern of respiratory chain enzymes as a result of selective deficiency of the mitochondrial ATP synthase. Pediatr. Res. 2004, 55, 988-994.
  29. Villanueva-Paz, M.; Povea-Cabello, S.; Villalón-García, I.; Álvarez-Córdoba, M.; Suárez-Rivero, J.M.; Talaverón-Rey, M.; Jackson, S.; Falcón-Moya, R.; Rodríguez-Moreno, A.; Sánchez-Alcázar, J.A. Parkin-mediated mitophagy and autophagy flux disruption in cellular models of MERRF syndrome. Biochim. Biophys. Acta Mol. Basis Dis. 2020, 1866, 165726.
  30. Panneman, D.M.; Wortmann, S.B.; Haaxma, C.A.; Van Hasselt, P.M.; Wolf, N.I.; Hendriks, Y.; Küsters, B.; Van Emst-De Vries, S.; Van de Westerlo, E.; Koopman, W. J. et al. Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction. Clin. Genet. 2020, 97, 556-566.
  31. Vantroys, E.; Larson, A.; Friederich, M.; Knight, K.; Swanson, M.A.; Powell, C.A.; Smet, J.; Vergult, S.; De Paepe, B.; Seneca, S. et al. New insights into the phenotype of FARS2 deficiency. Mol. Genet. Metab. 2017, 122, 172-181.
  32. Van Coster, R.; Smet, J.; George, E.; De Meirleir, L.; Seneca, S.; Van Hove, J.; Sebire, G.; Verhelst, H.; De Bleecker, J.; Van Vlem, B. et al. Blue native polyacrylamide gel electrophoresis: a powerful tool in diagnosis of oxidative phosphorylation defects. Pediatr. Res. 2001, 50, 658-665.
  33. Smet, J.; De Paepe, B.; Seneca, S.; Lissens, W.; Kotarsky, H.; De Meirleir, L.; Fellman, V.; Van Coster, R. Complex III staining in blue native polyacrylamide gels. J. Inherit. Metab. Dis. 2011, 34, 741-747.
  34. Devreese, B.; Vanrobaeys, F.; Smet, J.; Van Beeumen, J.; Van Coster, R. Mass spectrometric identification of mitochondrial oxidative phosphorylation subunits separated by two-dimensional blue-native polyacrylamide gel electrophoresis. Electrophoresis 2002, 23, 2525-2533.
  35. Schägger, H.; von Jagow, G. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal. Biochem. 1991, 199, 223-231.
  36. De Paepe, B.; Smet, J.; Vanlander, A.; Seneca, S.; Lissens, W.; De Meirleir, L.; Vandewoestyne, M.; Deforce, D.; Rodenburg R.J.; Van Coster, R. Fluorescence imaging of mitochondria in cultured skin fibroblasts: a useful method for the detection of oxidative phosphorylation defects. Pediatr. Res. 2012, 72, 232-240.
  37. Mezghani, N.; Mnif, M.; Mkaouar-Rebai, E.; Kallel, N.; Salem, I.H.; Charfi, N.; Abid, M.; Fakhfakh, F. The mitochondrial ND1 m.3337G>A mutation associated to multiple mitochondrial DNA deletions in a patient with Wolfram syndrome and cardiomyopathy. Biochem. Biophys. Res. Commun. 2011, 411, 247-252.
  38. Grady, J.P.; Pickett, S.J.; Ng, Y.S.; Alston, C.L.; Blakely, E.L.; Hardy, S.A.; Feeney, C.L., Bright, A.A.; Schaefer, A.M.; Gorman, G.S. et al. mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease. EMBO Mol. Med. 2018, 10, e8262.
  39. Lombès, A.; Auré, K.; Bellanné-Chantelot, C.; Gilleron, M.; Jardel, C. Unsolved issues related to human mitochondrial diseases. Biochimie 2014, 100, 171-176.
  40. Wallace, D.C.; Fan, W.; Procaccio, V. Mitochondrial energetics and therapeutics. Annu. Rev. Pathol. 2010, 5, 297-348.
  41. Swalwell, H.; Blakely, E.L.; Sutton, R.; et, al. A homoplasmic mtDNA variant can influence the phenotype of the pathogenic m.7472Cins MTTS1 mutation: are two mutations better than one? Eur. J. Hum. Genet. 2008, 16, 1265-1274.
  42. D'Aurelio, M.; Vives-Bauza, C.; Davidson, M.M.; Manfredi, G. Mitochondrial DNA background modifies the bioenergetics of NARP/MILS ATP6 mutant cells. Hum. Mol. Genet. 2010, 19, 374-386.
  43. Kirby, D.M.; Thorburn, D.R.; Turnbull, D.M.; Taylor, R.W. Biochemical assays of respiratory chain complex activity. Methods Cell Biol. 2007, 80, 93-119.
  44. Jesina, P.; Tesarová, M.; Fornůsková, D.; Vojtísková, A.; Pecina, P.; Kaplanová, V.; Hansíková, H.; Zeman, J.; Houstek, J. et al. Diminished synthesis of subunit a (ATP6) and altered function of ATP synthase and cytochrome c oxidase due to the mtDNA 2 bp microdeletion of TA at positions 9205 and 9206. Biochem. J. 2004, 383, 561-571